Intrum delivers rising servicing margins and organic growth as personnel cuts and AI integration offset FX risks and 2027 ...
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2025 Earnings Call Transcript February 12, 2026 Ultragenyx Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $-1.29 EPS, expectations ...
“He seems to have a lot of energy around reducing regulation, and if I can help him do that, I'm going to help him.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results